Mitochondrial DNA: An Endogenous Trigger for Immune Paralysis

Simon T Schäfer1, Lars Franken, Michael Adamzik

  • 1From the Klinik für Anästhesiologie und Intensivmedizin, Universität Duisburg-Essen and Universitätsklinikum Essen, Essen, Germany (S.T.S., M.A., A.E., N.S., J.W., J.P.); Institut für molekulare Medizin und experimentelle Immunologie, Universität Bonn, Bonn, Germany (L.F., C.K.); Klinik für Anästhesiologie und operative Intensivmedizin, Knappschaftskrankenhaus Bochum und Ruhruniversität Bochum, Bochum, Germany (M.A.); Institut für Medizinische Mikrobiologie, Immunologie und Parasitologie, Universität Bonn, Bonn, Germany (B.S.); Klinische Epidemiologie, Integriertes Forschungs- und Behandlungszentrum (IFB) Sepsis und Sepsisfolgen - Center for Sepsis Control and Care (CSCC), Universitätsklinikum Jena, Jena, Germany (A.S.); Klinik und Poliklinik für Dermatologie und Allergologie, Universität Bonn, Bonn, Germany (S.K., T.B.); Institut für Pathologie, Universität Duisburg-Essen and Universitätsklinikum Essen, Essen, Germany (H.A.B.); Institut für Medizinische Mikrobiologie, Universität Duisburg-Essen and Universitätsklinikum Essen, Essen, Germany (J.S., A.M.W.); Institut für Physiologie, Universität Duisburg-Essen, Essen, Germany (J.F., S.F.); Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Universitätsklinikum Bonn, Bonn, Germany (S.F.); and Klinik für Orthopädie und Unfallchirurgie, Universitätsklinikum Bonn, Bonn, Germany (A.L.).

Anesthesiology
|January 26, 2016
PubMed
Abstract

Insights

Mitochondrial DNA (mtDNA) is a novel inducer of septic immunoparalysis in critically ill patients. Elevated mtDNA levels in sepsis patients correlate with increased mortality, highlighting its role in immune suppression.

Area of Science:

  • Immunology
  • Critical Care Medicine
  • Molecular Biology

Background:

  • Critically ill patients exhibit heightened sepsis susceptibility due to unclear molecular mechanisms, including immune suppression.
  • While microbial triggers are known, the role of endogenous ligands like mitochondrial DNA (mtDNA) in sepsis-induced immune alterations is unexplored.

Purpose of the Study:

  • To investigate the role of endogenous mitochondrial DNA (mtDNA) as a potential inducer of immune suppression in sepsis.
  • To determine the association between serum mtDNA levels and sepsis outcomes.

Main Methods:

  • Quantified serum mtDNA (D-Loop, ATPase 6) in septic patients and healthy volunteers using qPCR.
  • Assessed T-cell cytotoxicity in wild-type and Toll-like receptor 9 (TLR9) knockout mice following mtDNA administration and viral vector injection.

Main Results:

  • Septic patients showed significantly elevated serum mtDNA concentrations compared to controls.
  • mtDNA administration induced TLR9-dependent immunosuppression in mice, impairing T-cell cytotoxicity and altering immune cell populations.
  • Elevated mtDNA levels in patients correlated with increased 30-day mortality.

Conclusions:

  • Mitochondrial DNA (mtDNA) acts as an endogenous danger-associated molecular pattern and a novel inducer of septic immunoparalysis.
  • mtDNA may bridge the gap between initial inflammation and subsequent immunosuppression in critically ill patients.